期刊文献+

长期血液透析患者丙型肝炎病毒感染的研究 被引量:2

Investigation of hepatitis C virus infection in chronic hemodialytic patients
暂未订购
导出
摘要 目的 调查长期血液透析患者丙型肝炎感染状况。方法 用酶联免疫吸附试验 ( EL ISA)法和RT- PCR法检测 13 7例长期血液透析患者血清中的抗丙型肝炎病毒 ( HCV)和丙型肝炎病毒核糖核酸( HCVRNA) ,并且同时检测丙氨酸转氨酶 ( AL T)和天冬氨酸转氨酶 ( AST) ,计算其变动率。结果  13 7例长期血液透析患者中仅抗 HCV阳性 8例 ,仅 HCVRNA阳性 15例 ,抗 HCV与 HCVRNA同时阳性者 2 4例 ,感染率3 4 .3 %。且透析时间 <2 a的 HCV感染率为 15 % ,透析时间 >2 a以上的其感染率增至 3 7.6%。结论 血透患者中 HCV的感染应引起重视 ,透析的年限越长 ,被 HCV感染的机率就越大。酶学指征的变动率不能作为长期透析患者 Objective To investigate the hepatitis C infection in chronic hemodialytic (HD) patients and the change of aminotransferase.Methods One hundred and thirty seven HD patients were evaluated by using ELISA to detect serum anti HCV antibodies,RT PCR to detect serum HCVRNA,and at the same time detect alanine aminotransferase and aspartate aminotransferase.Results Eight patients were only anti HCV positive,15 patients were only HCVRNA positive,24 patients were both anti HCV and HCVRNA positive,the total positive rate of HCV markers was 34.3%.Conclusion The prevalence of HCV infection in hemodialytic patients is serious,transaminases are not a sensitive marker for chronic hemodialytic patients.
机构地区 中日友好医院
出处 《山西医药杂志》 CAS 2001年第5期390-392,共3页 Shanxi Medical Journal
关键词 血液透析 丙型肝炎病毒感染 酶学指征 ELISA RT-PCR Hemodialytic Hepatitis C virus
  • 相关文献

参考文献2

二级参考文献1

  • 1Fan S T,J Immunol,1993年,150卷,2972页

共引文献22

同被引文献20

  • 1曹娅丽,王世相.维持性血液透析患者丙型肝炎病毒感染的研究进展[J].中国血液净化,2005,4(12):674-677. 被引量:7
  • 2Othman B, Monem F. Prevalence of antibodies to hepatitis C virus among hemodialysis patients in Damascus, Syria[J]. Infection, 2001,29(5):262 - 265.
  • 3Hinriehsen H, Leimenstoll G, Stegen G, et al. Prevalence and risk factors of hepatitis C virus infection in hemodialysis patiens[J]. Liver disease Gul, 2002,51:429- 433.
  • 4Petrosillo N, Gilli P, Serraino D, et al. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis[J]. Am J Kidney Dis, 2001,37 (5): 1004- 1010.
  • 5Carameio C,Ortiz A,Aquilera B,“ al. Liver disease patternsin hemodialysis patients, with antibodies to hepatitis C virus[J]. Am J Kidney Dis, 1993,22(6) :822 - 828.
  • 6and risk factors for hepatitis C seroconversion in hemodialysis:a prospective study. The UCL Collaborative Group [J]. Kid- ney Int,1993,44(6):1322 - 1326.
  • 7Donahue J G,Munoz A,Ness P M, etal. The declining risk ofpost transfusion hepatitis C virus infection[J]. N Engl J Med,1992,327(6) :369-375.
  • 8Hinrichsen H,Leimenstoll G, StegenG? etal. Prevalence andrisk factors of hepatitis C virus infection in hemodialysis pa~tients[J]. Liver disease Gul,2002,51(3) :429 - 433.
  • 9Okamoto H’Okatla S,Sugiyama Y,et al. The 5 terminal se-quence of the hepatitis C virus genome[J]. Jpn J Exp, 1990,60(3):167- 177.
  • 10Petrosillo N, Gilli P,Serraino D,et al. Prevalence of infectedpatients and understaffing have a role in hepatitis C virustransmission in dialysis[J]. Am J Kidney Dis, 2001,37(5):1004- 1010.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部